Written by DTC Wellness Testing Market Overview
The U.S. DTC wellness testing market is estimated to reach $4,946.3 million in 2032, reveals the premium market intelligence study. The study also highlights that the market is set to witness a CAGR of 18.86% during the forecast period 2022-2032.
The market for U.S. direct-to-consumer wellness testing has grown considerably. The awareness among consumers about DTC wellness testing is increasing, and this has led to the bio boom of wellness services. Another factor that has accelerated the market growth, is the rising focus of consumers towards health and fitness, rising number of illnesses, personalized wellness experience for consumers, and authentic health and wellness influencers. In addition, DTC brands are also offering services to their consumers through in-built health and wellness applications which is propelling the overall market growth.
USP of the Report
• Extensive competitive benchmarking of the top 13 public players and three emerging companies
• Market ranking analysis based on product portfolio, recent developments, and regional spread
• Investment landscape, including product adoption scenario, funding, and patent analysis
Analyst Perspective
According to Nitish Kumar, Lead Analyst of the report, “Direct-to-consumer tests (DTC) wellness testing helps customers to deliver a customized solution based on their test requirements. It does not involve the health care provider, and these tests generally request the consumer to collect a specimen, such as blood, saliva, or urine, and send it to the company for testing and analysis. In recent years, several companies have started selling wellness tests via online channels. Overall, these tests are supposed to guide the user towards more informed decisions about lifestyle choices.”
Key Companies Operating in The Market
Key players in the U.S. DTC wellness testing analyzed and profiled in the study provides wellness products and services such as hormones, micronutrients, food sensitivity, and food intolerance. Moreover, a detailed competitive benchmarking of the players operating in the U.S. DTC wellness testing has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
The key players profiled in the report include 23andMe Inc., Cue., Everlywell, Inc., Kindbody, Laboratory Corporation of America Holdings, LetGetChecked (PrivaPath Diagnostics Ltd.), myLAB Box., Myriad Genetics, Inc., Quest Diagnostics, Ro (Modern Fertility), Tomorrow’s Health, and Viome Life Sciences, Inc.
Key Questions Answered in the Report/h3>
• What are the major market drivers, challenges, and opportunities in the U.S. DTC wellness testing market?
• What are the underlying structures resulting in the emerging trends within the U.S. DTC wellness testing market?
• How is each segment of the U.S. DTC wellness testing market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2032?
• What are the key developmental strategies implemented by the major players to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for DTC wellness testing in the U.S.?
• Who are the leading players with significant offerings to the U.S. DTC wellness testing market, and what is the current market dominance for each of these leading players?
• What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2022-2032?
• Which DTC wellness testing type is anticipated to have the most promising growth?
• Who are the key manufacturers in the U.S. DTC wellness testing market, and what are their contributions? Also, what is the growth potential of each major DTC wellness testing manufacturer?
• What is the scope of the U.S. DTC wellness testing market? Which DTC wellness testing application and sample type is expected to dominate the U.S. market?
• What are the emerging trends in the U.S. DTC wellness testing market? How are these trends revolutionizing diagnostic procedures?
• Which companies are anticipated to be highly disruptive in the future, and why?
• What are the regulatory procedures that are required to unify the approval process for emerging DTC wellness testing?